Use of Outpatient Pharmacological Treatment Among Infants Born with Neonatal Abstinence Syndrome: Medicaid 2008-2017
ASPE ISSUE BRIEF
Mir M. Ali, Emma Nye, and Kristina West
U.S. Department of Health and Human Services
Office of the Assistant Secretary for Planning and Evaluation
Link to HTML Version (5 PDF pages)
ABSTRACT: This paper examines trends in outpatient pharmacological treatment among infants with Neonatal Abstinence Syndrome (NAS) between 2008 and 2017 in the United States, using a multi-state Medicaid claims database.
This brief was prepared through intramural research by the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, Office of Behavioral Health, Disability, and Aging Policy. For additional information about this subject, you can visit the BHDAP home page at https://aspe.hhs.gov/bhdap or contact the authors at HHS/ASPE/BHDAP, Room 424E, H.H. Humphrey Building, 200 Independence Avenue, S.W., Washington, D.C. 20201, Mir.Ali@hhs.gov, Emma.Nye@hhs.gov, Kristina.West@hhs.gov.
DISCLAIMER: The opinions and views expressed in this brief are those of the authors. They do not reflect the views of the Department of Health and Human Services, the contractor or any other funding organization. This brief was completed and submitted in March 2020.